Allstate Corp vs Axogen Inc — how do they compare? Allstate Corp trades at $262 (market cap $66.31B), while Axogen Inc trades at $48.35 (market cap $2.61B). The key difference: Allstate Corp is far larger — about 25.4× Axogen Inc's market cap, and Allstate Corp pays a 1.65% dividend while Axogen Inc pays none. Which is the better fit depends on your goals.
| ALL | AXGN | |
|---|---|---|
Market Cap | $66.31B | $2.61B |
Sector | Financials | Technology |
52-Week High | $275.11 | $48.48 |
52-Week Low | $190.00 | $14.16 |
Enterprise Value | $74.96B | $2.52B |
Dividend Yield | 1.65% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
AXGN is trading at $46.43, up 4.69% today, with strong technical momentum and bullish moving average signals. The company reported Q2 2026 revenue growth of 23.1% to $69.7 million and raised full-year guidance to at least $279 million. Despite recent earnings misses, analyst sentiment remains overwhelmingly positive with 84% buy ratings and a $54.33 price target.
The stock presents growth potential driven by expanding nerve care platform adoption and reimbursement improvements, but faces risks from persistent net losses (-$15.7M in 2025) and high valuation multiples (P/S 9.5). Near-term performance hinges on Q3 earnings delivery and continued commercial execution amid competitive pressures.
Trailing returns across standard periods
Latest headlines on both assets
On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.
Read more on ALL →Axogen is a leader in peripheral nerve regeneration and repair. It provides innovative surgical solutions and clinically proven products, like nerve grafts, to help restore function and quality of life for patients.
Read more on AXGN →